Approved Vaccines

Last Updated 15 October 2021.

23 Vaccines Approved by at Least One Country

The vaccines listed below are those that have been approved, authorized, licensed, granted emergency use authorization, or made available for use outside of clinical trials via any pathway by a regulatory agency, a national authority, or another entity.

• Anhui Zhifei Longcom
  ZF2001

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 3 countries

  8 trials in 1 country

  Protein Subunit

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 9 countries

  7 trials in 1 country

  Inactivated

• CanSino
  Ad5-nCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 9 countries

  11 trials in 1 country

  Non Replicating Viral Vector

• Center for Genetic Engineering and Biotechnology (CIGB)
  CIGB-66

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  5 trials in 1 country

  Protein Subunit

• Chumakov Center
  KoviVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  Inactivated

• FBRI
  EpiVacCorona

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  3 trials in 1 country

  Protein Subunit

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 18 countries

  4 trials in 2 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  21 trials in 2 countries

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 75 countries

  13 trials in 2 countries

  Non Replicating Viral Vector

• Kazakhstan RIBSP
  QazVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  3 trials in 1 country

  Inactivated

• Medigen
  MVC-COV1901

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 1 country

  Protein Subunit

• Minhai Biotechnology Co
  SARS-CoV-2 Vaccine (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  5 trials in 1 country

  Inactivated

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 76 countries

  30 trials in 2 countries

  RNA

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 124 countries

  45 trials in 2 countries

  Non Replicating Viral Vector

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 103 countries

  37 trials in 2 countries

  RNA

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 46 countries

  2 trials in 1 country

  Non Replicating Viral Vector

• Shifa Pharmed Industrial Co
  COVID-19 Inactivated Vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  4 trials in 1 country

  Inactivated

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 66 countries

  14 trials in 2 countries

  Inactivated

• Sinopharm (Wuhan)
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  8 trials in 7 countries

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 41 countries

  22 trials in 1 country

  Inactivated

• Takeda
  TAK-919 (Moderna formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  RNA

• Vaxine/CinnaGen Co.
  COVAX-19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  4 trials in 2 countries

  Protein Subunit

• Zydus Cadila
  ZyCoV-D

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  5 trials in 1 country

  DNA